Methotrexate has been frequently employed to treat ocular inflammatory diseases including uveitis, scleritis, and orbital inflammatory disease. It is effective for intraocular lymphoma when given directly into the eye. No study has assessed its efficacy for eye disease in a randomised, placebo controlled design. This report reviews the literature relevant to methotrexate's utility in the treatment of ocular inflammatory disease.
|Original language||English (US)|
|Journal||Clinical and experimental rheumatology|
|Issue number||5 SUPPL. 61|
|State||Published - Dec 30 2010|
ASJC Scopus subject areas
- Immunology and Allergy